Rxo, Inc.
RXO
Rxo, Inc.
Financials Mid Cap Updated Feb 13, 2026

RXO did $4.3B of quarterly revenue, lost money, and still carries an 18-month target of $28.

If you own RXO, you’re betting freight demand rebounds before thin profits crack again.

$15.49
Market cap ~$2B · 52-week range $10–$16
44
Composite
Our overall rating — combines growth, value, risk, and momentum
44
/ 100

Below Average

Combines growth, value, risk, and momentum factors into a single institutional-grade score.

What it is
RXO helps shippers find truck capacity fast, then takes a fee without owning most of the trucks.
How it gets paid
Last year Rxo made $5.7B in revenue.
Why it's growing
Revenue grew 26.2% last year. Latest-quarter revenue rose 201% vs. prior year to $4.3B.
What just happened
RXO posted $4.3B of quarterly revenue, but earnings still missed and stayed negative.
B+ balance sheet — decent shape, but not bulletproof
25.8x trailing p/e — priced about right
8.0% return on capital — nothing to write home about
XVARY composite: 44/100 — below average
$0.60 fy2027 eps est
RXO helps shippers find truck capacity fast, then takes a fee without owning most of the trucks.
RXO’s edge is scale without fleets. Asset-light → it uses outside carriers instead of buying trucks → so what: long-term debt is $387M, just 13% of capital, which keeps the balance sheet cleaner than an asset-heavy hauler. If you’re a shipper, you care about coverage and speed, and a platform doing $5.7B of annual revenue has both.
financials small-cap asset-light freight-brokerage cyclical
$5.7B annual revenue · their business grew +26.2% last year
total revenue
$5.7B
+26.2%
Brokered freight matching
Freight Brokerage Platform
$5.7B revenue · +26.2% growth
it's the core business. the platform matched shippers and carriers across a $5.7B revenue base last year, but the 1.4% net margin tells you the economics are still thin.
1.4% net margin
$28
18-month target
That target is 81% above $15.49, which tells you how washed out expectations already are.
4.5%
operating margin
Operating margin → profit before interest and taxes → so what: RXO has very little room for mistakes.
$387M
long-term debt
That is 13% of capital, which is manageable and fits the asset-light model.
1.55
beta
Beta → how jumpy a stock is versus the market → so what: RXO usually moves more than the index.
B+
Strength
  • balance sheet grade B+ — solid but not elite
  • risk rank 3 — safer than 50% of stocks
  • price stability 20 / 100
  • long-term debt $387M (13% of capital)
  • net profit margin 2.3% — keeps 2 cents of every dollar in revenue
  • return on equity 9% — $0.09 profit for every $1 investors have put in
B+ — functional but not a standout on the balance sheet.
source: institutional data · return history unavailable
missed estimates
RXO posted $4.3B of quarterly revenue, but earnings still missed and stayed negative.
Latest-quarter revenue rose 201% vs. prior year to $4.3B, while EPS was -$0.32. Yahoo Finance also shows the last earnings result at -$0.07 versus -$0.05 expected, so the broad message is the same: scale arrived faster than clean profit.
$4.3B
revenue
$0.32
eps
n/a
n/a
the number that mattered
The 201% revenue jump matters because it shows how much the Coyote deal changed RXO’s size, but not yet its earnings quality.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. Plain English, no spam.

Weekly updates Earnings alerts Plain English No spam

The #1 risk is margin compression in freight brokerage.

Med
Thin margins leave almost no buffer
RXO generated $5.7B of revenue last year but only a 1.4% net margin and 3.2% operating margin. In a brokerage model, that means small pricing mistakes or weaker freight demand show up quickly in earnings.
With profitability this thin, the difference between a good quarter and a bad one can be measured in pennies per share.
Med
The proposed $400M senior notes deal raises the pressure
RXO already carries $387M of long-term debt. If the proposed $400M senior notes offering closes, interest expense goes up while the business is still working through low-margin economics.
More debt on top of a 1.4% net margin is not a rounding error. It reduces the room management has to miss.
Med
Revenue can grow without shareholders feeling much of it
The business is expected to do $6B in revenue this year, yet EPS is only forecast at $0.05. That tells you the bear case clearly: scale keeps growing, but earnings power does not.
If revenue expands and EPS stays near breakeven, the stock stops looking cheap and starts looking structurally low-margin.
A $5.7B business earning a 1.4% net margin with $387M of debt does not have much margin for error. If the notes offering goes through, that cushion gets even thinner.
Source: institutional data · regulatory filings · risk analysis
Key metric
Operating margin above 3.2%
Revenue growth already happened. The next rerating needs operating margin to move above 3.2%, not just more freight volume.
Balance sheet
Whether the $400M notes deal gets done
RXO has $387M of long-term debt today. Another $400M would make the capital structure a much bigger part of the story.
Earnings
The next EPS print after a -$0.08 quarter
Full-year results improved, but the latest quarter still lost money. You want to see whether that quarterly line moves toward positive territory.
Trend
Bottom-5% momentum rank versus a stock near its 52-week high
The stock is near the top of its $10–$16 range, yet the technical score is 5. Either the chart improves, or the price has some explaining to do.
short-term outlook
below average
momentum score 4 — in human-speak, analysts expect weaker relative performance in the next stretch.
risk profile
average
stability score 3 — the balance sheet is decent, but the business model still carries normal cyclical risk.
chart momentum
bottom 5%
technical score 5 — the chart is weak enough that the stock is fighting the tape even with a long-term target above today's price.
Source: institutional data

institutions have been net buying for 2 consecutive quarters — 135 buyers vs. 116 sellers in 3q2025. total institutional holdings: 0.2B shares. net buying for 2 quarters.

Source: institutional data
3-5 year target range
$12 $44
$15 Current price
$28 Target midpoint · +81% from current · 3-5yr high: $30 (+95% · 19% ann'l return)
source: institutional data · analyst targets

Want the deeper analysis?

The full deep dive: DCF model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

See plans from $5/mo
RXO
XVARY Deep Dive
rxo
The full analysis is in the works.
What you'll get
DCF valuation model
Bull / base / bear scenarios
Competitive moat breakdown
Quarterly earnings tracker
Operating model projections
Risk matrix with kill criteria
Original price target + conviction
Updated with every earnings
Free · no spam · you'll be first to read it